Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - TOTAL RECEIVABLES
Total Receivables EXEL - Exelixis, Inc.
265 M
LAST VALUE
11.17%
2 YEAR CAGR
17.39%
5 YEAR CAGR
49.12%
10 YEAR CAGR